Aerie Pharmaceuticals Skyrockets On Eye Drug News

September 14, 2016 8:10 PM

6 0

Aerie Pharmaceuticals Skyrockets On Eye Drug News

Aerie Pharmaceuticals (AERI) spiked before the open on the stock market today after reporting positive trial data for an eye pressure drug late Wednesday.

In a late-stage trial, Aerie Pharma's Roclatan lowered fluid pressure within the eye, outperforming latanoprost or Rhopressa, another Aerie treatment.

Also read: Why Campbell Soup Company (CPB) Stock Is Sinking Today

Read more

To category page

Loading...